发明名称 |
LEVOSIMENDAN FOR USE AS A LIVER PROTECTOR |
摘要 |
The present invention relates to the administration of levosimendan during liver cirrhosis: the administration of levosimendan reduces the formation of fibrotic nodules in the liver and thus the concentration of bilirubin in blood. The administration of levosimendan reduces the suffering of liver wherein cirrhosis was induced and this is demonstrated by the reduced levels of AST and ALT. Levosimendan improves the metabolism and thus the brain functionality during liver cirrhosis. |
申请公布号 |
WO2016079652(A1) |
申请公布日期 |
2016.05.26 |
申请号 |
WO2015IB58845 |
申请日期 |
2015.11.16 |
申请人 |
UNIVERSITÀ DEGLI STUDI DI SALERNO |
发明人 |
PIAZZA, ORNELLA;SCARPATI, GIULIANA |
分类号 |
A61K31/50;A61K9/08;A61P1/16 |
主分类号 |
A61K31/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|